TLR9 and systemic lupus erythematosus: However, the mice in the IRS-954-nanoflower-treated group did not show obviously attenuated effects on lupus manifests, although ODN IRS 954 was believed to be a dual antagonist that could bind to both TLR7 and TLR9.